Rekvina Laboratories Limited (BSE: 526075)
Health Care · Pharmaceuticals · IN
Rs49.86
-0.08% today · +604.2% 1Y
Rekvina Laboratories Limited (BSE: 526075) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.76M.
Over the last twelve months the share price has gained 604.2%, trading between 6.75 and 59.40.
Tweenvest scores Rekvina Laboratories Limited across four factors: quality 19/100, value 79/100. Its strongest factor is value.
526075 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.76M
- Revenue (TTM)
- $204.53K
- P/E
- —
- EPS
- -0.56
- Dividend yield
- —
- Beta (5Y)
- 2.81
- 52-week high
- Rs59.40
- 52-week low
- Rs6.75
- Avg volume (3M)
- —
- Shares outstanding
- 11.12M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cardiac Biotech Solutions Inc.OTCPK: CBSC | $5.97M | $0.04 | +11.29% |
| Sonoma Pharmaceuticals, Inc.NasdaqCM: SNOA | $5.84M | $1.17 | -4.10% |
| Gelteq LimitedNasdaqCM: GELS | $5.83M | $0.56 | +7.40% |
| Invex Therapeutics LtdASX: IXC | $5.81M | AU$0.11 | -4.35% |
| Pulmatrix, Inc.NasdaqCM: PULM | $5.73M | $1.59 | +1.27% |
| Stenocare A/SCPSE: STENO | $5.66M | Dkr0.73 | -15.63% |
| Firebrick Pharma LimitedASX: FRE | $5.57M | AU$0.03 | +7.69% |
| Lamdong Pharmaceutical Joint Stock CompanyHNX: LDP | $5.55M | ₫7,700.00 | -1.28% |
Figures last refreshed Oct 4, 2026.